James N. Ingle

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2

Erin E. Carlson, D. Schaid, C. Vachon, 2015, Breast Cancer Research and Treatment.

A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.

K. Brandt, E. Perez, A. Degnim, 2007, Mayo Clinic proceedings.

Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion

R. Weinshilboum, Liewei Wang, M. Kubo, 2017, Breast Cancer Research.